NCT05764317

Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)

DescripTion of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/atoRvastatin/Perindopril sinGle Pill Combination trEatmenT in Patients With Arterial Hypertension and Dyslipidemia in the Daily Clinical Practice. (TARGET)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 409 (actual)
• Sponsor: Servier Russia · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: —

Summary

This is a multi-centre, observational, ambispective study, which will retrospectively and prospectively collect clinical and socio-demographic data from medical records of patients with HTN and dyslipidemia initiated with SPC of amlodipine/atorvastatin/perindopril in real clinical settings. A total of 80 general practitioners and outpatient cardiologists will participate in this non-interventional study 400 patients should be included in the study.

Detailed description

Treatment with the studied drug: * Amlodipine 5 mg + atorvastatin 10 mg + perindopril arginine 5 mg * Amlodipine 5 mg + atorvastatin 20 mg + perindopril arginine 5 mg * Amlodipine 5 mg + atorvastatin 20 mg + perindopril arginine 10 mg This is non-interventional study that is observational by its nature. Therefore there will be no any assignments of subjects to a particular therapeutic strategies defined by this protocol. Decision to treat a patient with SPC of amlodipine/ atorvastatin/ perindopril should be at the descretion of a treating investigator and made in accordance to local standards and protocols.

Conditions

• Arterial Hypertension
• HTN

Interventions

Type	Name	Description
DRUG	Amlodipine 5 mg + atorvastatin 10 mg + perindopril arginine 5 mg	a triple fixed combination of atorvastatin, perindopril and amlodipinedose combinations, was in a 3-month in accordance to the instruction for medical use approved in the Russian Federation
DRUG	Amlodipine 5 mg + atorvastatin 20 mg + perindopril arginine 5 mg	a triple fixed combination of atorvastatin, perindopril and amlodipinedose combinations, was in a 3-month in accordance to the instruction for medical use approved in the Russian Federation
DRUG	Amlodipine 5 mg + atorvastatin 20 mg + perindopril arginine 10 mg	a triple fixed combination of atorvastatin, perindopril and amlodipinedose combinations, was in a 3-month in accordance to the instruction for medical use approved in the Russian Federation

Timeline

• Start date: 2023-04-30
• Primary completion: 2023-11-30
• Completion: 2024-02-20
• First posted: 2023-03-10
• Last updated: 2024-04-19

Locations

1 site across 1 country: Russia